{
    "clinical_study": {
        "@rank": "121152", 
        "acronym": "REIVI", 
        "biospec_descr": {
            "textblock": "Whole blood"
        }, 
        "biospec_retention": "None Retained", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the sensitivity and specificity of QuantiFeron\u00ae\n      and ImmuKnow\u00ae in combination for early detection of patients who will develop CMV infection\n      in lung transplant patients with CMV-positive serology (R+) prior to transplant."
        }, 
        "brief_title": "Evaluate Cytomegalovirus (CMV)-Specific Response Measured by QuantiFeron\u00ae and Overall Immunologic Response Measured by ImmuKnow\u00ae in Lung Transplant Patients With CMV-positive Serology (R+) Prior to Transplant and Its Involvement in the Development of CMV Infection", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Cytomegalovirus", 
        "condition_browse": {
            "mesh_term": "Cytomegalovirus Infections"
        }, 
        "detailed_description": {
            "textblock": "The secondary objectives of the study are:\n\n        -  To evaluate Cytomegalovirus (CMV)-specific immune response measured by QuantiFeron\u00ae.\n\n        -  To evaluate overall immune response measured by ImmuKnow\u00ae.\n\n        -  To study the course of QuantiFeron\u00ae and ImmunKnow\u00aeover the follow-up period.\n\n        -  To correlate levels of ImmuKnow\u00ae and QuantiFeron\u00ae.\n\n        -  To evaluate the relationship between levels and doses of immunosuppressants and their\n           relationship to degree of overall immunosuppression (ImmuKnow\u00ae).\n\n        -  To evaluate the relationship between infections, immunological complications and degree\n           of overall immunosuppression (ImmuKnow\u00ae)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients aged \u2265 18 years.\n\n          -  Men or women who have received a lung transplant.\n\n          -  CMV-seropositive patients (R+).\n\n          -  Patients who have been informed of the study procedures and have signed the informed\n             consent form.\n\n          -  Over 3 months posttransplant.\n\n        Exclusion Criteria:\n\n          -  Patients who are not expected to be able to be followed during the first 12 months\n             posttransplant.\n\n          -  Patient participation in another clinical trial or study will not be a criterion for\n             exclusion."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "CMV-positive (R+) lung transplant patients"
            }
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02076971", 
            "org_study_id": "FUN-CMV-2013-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lung transplant", 
            "Quantiferon", 
            "Immuknow"
        ], 
        "lastchanged_date": "March 3, 2014", 
        "location": [
            {
                "contact": {
                    "email": "jose492@separ.es", 
                    "last_name": "Jos\u00e9 Cifr\u00edan, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Santander", 
                        "country": "Spain", 
                        "state": "Cantabria", 
                        "zip": "39008"
                    }, 
                    "name": "Hospital Universitario Marqu\u00e9s de Valdecilla"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 Cifri\u00e1n, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pusetti.hpth@salud.madrid.org", 
                    "last_name": "Piedad Ussetti, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Majadahonda", 
                        "country": "Spain", 
                        "state": "Madrid", 
                        "zip": "28222"
                    }, 
                    "name": "Hospital Universitario Puerta de Hierro Majadahonda"
                }, 
                "investigator": {
                    "last_name": "Piedad Ussetti, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Jose.MA.Borro.Mate@sergas.es", 
                    "last_name": "Jos\u00e9 M Borro, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "A Coru\u00f1a", 
                        "country": "Spain", 
                        "zip": "15006"
                    }, 
                    "name": "Hospital Universitario A Coru\u00f1a"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 M Borro, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "vmonforte@vhebron.net", 
                    "last_name": "Victor Monforte, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08035"
                    }, 
                    "name": "Hospital Vall d'Hebr\u00f3n"
                }, 
                "investigator": {
                    "last_name": "Victor Monforte, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "fsantos1957@hotmail.com", 
                    "last_name": "Francisco Santos, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "C\u00f3rdoba", 
                        "country": "Spain", 
                        "zip": "14004"
                    }, 
                    "name": "Hospital Universitario Reina Sof\u00eda"
                }, 
                "investigator": {
                    "last_name": "Francisco Santos, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "vluz71@hotmail.com", 
                    "last_name": "Virginia P\u00e9rez, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28041"
                    }, 
                    "name": "Hospital Universitario 12 de Octubre"
                }, 
                "investigator": {
                    "last_name": "Virginia P\u00e9rez, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sole_amp@gva.es", 
                    "last_name": "Amparo Sol\u00e9, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46026"
                    }, 
                    "name": "Hospital Universitario y Polit\u00e9cnico la Fe"
                }, 
                "investigator": {
                    "last_name": "Amparo Sol\u00e9, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Multicenter Prospective Observational Study to Evaluate Cytomegalovirus (CMV)-Specific Response Measured by QuantiFeron\u00ae and Overall Immunologic Response Measured by ImmuKnow\u00ae in Lung Transplant Patients With CMV-positive Serology (R+) Prior to Transplant and Its Involvement in the Development of CMV Infection", 
        "overall_contact": {
            "email": "vmonforte@vhebron.net", 
            "last_name": "Victor Monforte, MD", 
            "phone": "+34932746065"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital Vall d'Hebron", 
                "last_name": "Victor Monforte, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital Puerta de Hierro", 
                "last_name": "Piedad Ussetti, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital Vall d'Hebron Laboratory", 
                "last_name": "Susana G\u00f3mez, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital Vall d'Hebr\u00f3n", 
                "last_name": "Victor Monforte, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Puerta Hierro", 
                "last_name": "Piedad Ussetti, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Reina Sof\u00eda", 
                "last_name": "Francisco Santos, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Marqu\u00e9s de Valdecilla", 
                "last_name": "Jos\u00e9 Cifri\u00e1n, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Universitario A Coru\u00f1a", 
                "last_name": "Jos\u00e9 M Borro, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital 12 de Octubre", 
                "last_name": "Virginia P\u00e9rez, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Universitario La Fe", 
                "last_name": "Amparo Sol\u00e9, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Spanish Agency of Medicines", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Quantiferon\u00ae is assessed multiple times and it will be considered positive when first positive test is assessed.", 
                "measure": "Quantification of interferon-\u03b3 produced by specific CD8+ T cells after ex-vivo stimulation with various CMV epitopes using the commercial assay QuantiFeron\u00ae- CMV", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }, 
            {
                "description": "InmunKnow\u00ae is assessed multiple times and it will be considered positive when first positive test is assessed.", 
                "measure": "Measurement of overall immune response by determination of the activity of CD4+ T cells", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }, 
            {
                "description": "PCR is assessed multiple times and it will be considered positive when first positive test is assessed.", 
                "measure": "Quantification of CMV viral replication in blood measured by PCR", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02076971"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fundacio Catalana de Pneumologia", 
            "investigator_full_name": "Victor Monforte", 
            "investigator_title": "Hospital Vall d'Hebron", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Measurement of immunosuppressive drugs: Blood levels of calcineurin inhibitors (tacrolimus or cyclosporine). Mycophenolate (or equivalent) dose and corticosteroid doses.", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }, 
            {
                "measure": "Complete blood count (WBC count) and routine biochemistry", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }, 
            {
                "measure": "Determination of glomerular filtration rate", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }, 
            {
                "measure": "Course of graft function by measuring GFR", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }, 
            {
                "measure": "Complications since last visit: Infections, rejection episodes, chronic graft dysfunction, other complications", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }, 
            {
                "measure": "CMV prophylaxis, drug and dosage. Serious Adverse events related or no related to the drug", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }, 
            {
                "measure": "Follow-up loss/death (if it occurs)", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months from transplant"
            }
        ], 
        "source": "Fundacio Catalana de Pneumologia", 
        "sponsors": {
            "collaborator": {
                "agency": "Roche Farma, S.A", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Fundacio Catalana de Pneumologia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}